GE HealthCare, DeepHealth expand mammography AI pact

GE HealthCare has expanded its collaboration with DeepHealth, a RadNet subsidiary, to broaden access to AI-powered mammography tools.

The agreement builds on a 2024 initiative that paired DeepHealth’s breast cancer screening workflow with GE HealthCare’s Senographe Pristina mammography system. The next phase will expand the relationship internationally and add second-reader workflow capabilities.

GE HealthCare said the expanded collaboration will bring new Breast Suite applications to its mammography systems, including Pristina Via. The suite includes a cloud-first multimodality viewer, cancer detection, automated density assessment, prioritized worklist, Timely Alerts, and reporting tools.

The new applications include ProFound Pro, which combines cancer detection with automated density assessment for lesion localization, degree-of-suspicion scoring, and density classification on 2D or 3D mammograms.

The collaboration also includes Safeguard Review, an optional AI-powered workflow that flags complex cases that may benefit from secondary review. DeepHealth noted that the feature is only available in the U.S.

DeepHealth cited a U.S. real-world analysis of 579,583 exams across 109 sites and 96 radiologists. The study found a 21% increase in cancer detection rate with a multistage AI-driven workflow compared with standard care, according to the announcement.

For women with dense breasts, the same workflow showed a 23% increase in cancer detection rate, the company said.

The announcement coincided with the Society of Breast Imaging Annual Symposium. GE HealthCare also planned to show Pristina Recon DL, Invenia ABUS Prime, and LOGIQ ultrasound systems at the meeting.